New arrangements for nitisinone (Orfadin®) – information for prescribers

This fact sheet is for current prescribers (treating physicians) with patients requiring treatment for hereditary tyrosinaemia type 1. It explains how a treatment for this condition, nitisinone (Orfadin®), will be transitioning from the Life Saving Drugs Program to the PBS.